Lipigon Pharmaceuticals AB's total assets for Q4 2025 were kr11.49M, a decrease of -36.48% from the previous quarter. SE:LPGO total liabilities were kr3.57M for the fiscal quarter, a 19.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.